Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
Price:
31.09
CNY
0.29%
Market Closed
Market Cap:
¥49.7B
Relative Value
The Relative Value of one
Sichuan Kelun Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 31.09 CNY,
Sichuan Kelun Pharmaceutical Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Sichuan Kelun Pharmaceutical Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Sichuan Kelun Pharmaceutical Co Ltd Competitors
Sichuan Kelun Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Sichuan Kelun Pharmaceutical Co Ltd
SZSE:002422
|
49.5B CNY | 2.7 | 29.6 | 20.8 | 20.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
987B USD | 15.1 | 47.8 | 32.2 | 34.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
592.7B USD | 6.3 | 22.1 | 15.3 | 18.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
298.4B CHF | 4.9 | 31.7 | 13.3 | 15.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.8B GBP | 5.5 | 31.7 | 17.5 | 24.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.3B CHF | 5.7 | 22.8 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
309B USD | 4.8 | 16.9 | 10.6 | 12.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.8 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.4B USD | 2.5 | 19.9 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.1B USD | 2.6 | 17.6 | 7.4 | 9.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
